HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cover Girl licensing agreement

This article was originally published in The Rose Sheet

Executive Summary

Procter & Gamble signs trademark agreement with contact lens manufacturer Concord, Calif.-based Ocular Sciences to market cosmetic contact lenses under the Cover Girl brand name in North America, P&G announces Jan. 14. Beginning this month, Cover Girl Colors Contact Lenses are marketed for disposable replacement to licensed eye care practitioners, firm says. Available in four opaque colors including Breezy Blue, Spirited Green, Romantic Hazel and Gray Whisper, Cover Girl Colors come in prescription and nonprescription lenses. Cover Girl eyewear frames, sunwear currently are sold in U.S. and internationally though agreements with Miami-based Marcolin and South Easton, Mass.-based Marine Optical (1"The Rose Sheet" Sept. 24, 2001, In Brief and 2"The Rose Sheet" March 20, 2000, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010929

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel